Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Recap by typeshit. Full story at Benzinga.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
Gen Z use beats every other generation, and appearance was its top reason. Korean regulators are also weighing tighter controls on Wegovy and Mounjaro.
The first four weeks cost around 129,800 won at supply price. Hanmi reports 9.75% average weight loss over 40 weeks and has set a 100 billion won first-year sales target.
The Daily Aus reports a coroner's finding that an allergic reaction to peptides led to Norton's death, a formal step in a case already raising safety concerns.
Loading…